Clinical trial
Post-Marketing Surveillance for Crohn's Disease Patients Treated With STELARA
NCT03942120 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Surveillance for Crohn's Disease Patients Treated With STELARA
- Lead sponsor
- Janssen Korea, Ltd., Korea
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 8, 2019
- Completion date
- January 14, 2022
- Enrollment
- 685 (actual)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.